Submit your research to be featured at LL&M Congress 2026, with awards given for top clinical and translational posters.
Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2026 Lymphoma, Leukemia & Myeloma Congress.
Accepted abstracts will be published in the American Journal of Hematology. Only abstracts received by the submission deadline will be published. Industry authors can be co-authors and lead authors.
Abstract Submission Deadline: July 15, 2026, 11:59 PM ET
Abstract Notifications Mailed/Notified: on or before September 10, 2026
Abstract Withdrawal Deadline: September 21, 2026
Abstract Presenter Registration Deadline: October 1, 2026
Important Poster Dates
Physical Poster Display Dates (posters will be displayed in the Exhibit Hall): October 13th-October 16th, 2026
Abstracts will be accepted in the following categories: ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES, or MULTIPLE MYELOMA, or CHRONIC LYMPHOCYTIC LEUKEMIA, and/or LYMPHOMA. Please indicate which category is appropriate by checking the appropriate box in the online submission system.
ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES CATEGORIES
Clinical Trials
Procedures and Diagnostics
Epidemiology and Outcomes Research
Clinical Case Reports
Trials in Progress
MULTIPLE MYELOMA CATEGORIES
Clinical Trials
Procedures and Diagnostics
Epidemiology and Outcomes Research
Clinical Case Reports
Trials in Progress
CHRONIC LYMPHOCYTIC LEUKEMIA CATEGORIES
Clinical Trials
Procedures and Diagnostics
Epidemiology and Outcomes Research
Clinical Case Reports
Trials in Progress
LYMPHOMA CATEGORIES
Clinical Trials
Procedures and Diagnostics
Epidemiology and Outcomes Research
Clinical Case Reports
Trials in Progress
LL&M Congress does NOT retain the copyright to the abstracts and posters presented at past or future conferences.
We look forward to receiving your exciting work! Please reach out to us at hseymour@hmpglobal.com if you have questions about abstract submission.
Due to being a fully live conference, we will not utilize virtual versions of posters. Simply bring your physical poster with you on site to New York. Accepted abstracts will be available for attendees to view in our Conference App, but you do not need to provide anything to us prior to being on site.
Yes, by being accepted, your abstract will automatically be published in journal supplement as well as be available to attendees via our Conference App.
Per to our guidelines, co-authors may present the poster on site at Lymphoma, Leukemia and Myeloma Congress.
Rather than providing handouts on site, we recommend adding a QR code to your poster that links to the additional information.
There is no required template for posters. As long as your poster fits within the provided sizing guidelines, feel free to design your posters however you would like!
Posters will be hung while the Exhibit Hall is open. Specific set up and tear down times will be provided to accepted poster presenters via email. We recommend standing by your poster during the Opening Reception and during Exhibit Hall breaks, but formal presentation times are not required.
Yes, you must register in order to present a poster at LL&M Congress
Yes, the complete abstract data is under embargo until after the conference on October 16, 2026.